Functional Analysis of Ficolin-3 Mediated Complement Activation

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2010 Nov 19

PMID 21085669

Citations 22

Authors

Estrid Hein

Christian Honore

Mikkel-Ole Skjoedt

Lea Munthe-Fog

Tina Hummelshoj

Peter Garred

Affiliations

Soon will be listed here.

Abstract

The recognition molecules of the lectin complement pathway are mannose-binding lectin and Ficolin -1, -2 and -3. Recently deficiency of Ficolin-3 was found to be associated with life threatening infections. Thus, we aimed to develop a functional method based on the ELISA platform for evaluating Ficolin-3 mediated complement activation that could be applicable for research and clinical use. Bovine serum albumin (BSA) was acetylated (acBSA) and chosen as a solid phase ligand for Ficolins in microtiter wells. Binding of Ficolins on acBSA was evaluated, as was functional complement activation assessed by C4, C3 and terminal complement complex (TCC) deposition. Serum Ficolin-3 bound to acBSA in a calcium dependent manner, while only minimal binding of Ficolin-2 and no binding of Ficolin-1 were observed. No binding to normal BSA was seen for any of the Ficolins. Serum C4, C3 and TCC deposition on acBSA were dependent only on Ficolin-3 in appropriate serum dilutions. Deposition of down stream complement components correlated highly significantly with the serum concentration of Ficolin-3 but not with Ficolin-2 in healthy donors. To make the assay robust for clinical use a chemical compound was applied to the samples that inhibited interference from the classical pathway due to the presence of anti-BSA antibodies in some sera. We describe a novel functional method for measuring complement activation mediated by Ficolin-3 in human serum up to the formation of TCC. The assay provides the possibility to diagnose functional and genetic defects of Ficolin-3 and down stream components in the lectin complement pathway.

Citing Articles

DIA-based proteomics analysis of serum-derived exosomal proteins as potential candidate biomarkers for intrahepatic cholestasis in pregnancy.

Nie L, Xin S, Zheng J, Luo Y, Zou Y, Liu X Arch Gynecol Obstet. 2022; 308(1):79-89.

PMID: 35849169 DOI: 10.1007/s00404-022-06703-0.

Integrative genetic and immune cell analysis of plasma proteins in healthy donors identifies novel associations involving primary immune deficiency genes.

Caron B, Patin E, Rotival M, Charbit B, Albert M, Quintana-Murci L Genome Med. 2022; 14(1):28.

PMID: 35264221 PMC: 8905727. DOI: 10.1186/s13073-022-01032-y.

Seroconversion stages COVID19 into distinct pathophysiological states.

Galbraith M, Kinning K, Sullivan K, Baxter R, Araya P, Jordan K Elife. 2021; 10.

PMID: 33724185 PMC: 7963480. DOI: 10.7554/eLife.65508.

Seroconversion stages COVID19 into distinct pathophysiological states.

Galbraith M, Kinning K, Sullivan K, Baxter R, Araya P, Jordan K medRxiv. 2020; .

PMID: 33330890 PMC: 7743101. DOI: 10.1101/2020.12.05.20244442.

Amyotrophic lateral sclerosis and the innate immune system: protocol for establishing a biobank and statistical analysis plan.

Kjaeldgaard A, Pilely K, Olsen K, Lauritsen A, Pedersen S, Moller K BMJ Open. 2020; 10(8):e037753.

PMID: 32759248 PMC: 7409992. DOI: 10.1136/bmjopen-2020-037753.

References

Munthe-Fog L, Hummelshoj T, Ma Y, Hansen B, Koch C, Madsen H . Characterization of a polymorphism in the coding sequence of FCN3 resulting in a Ficolin-3 (Hakata antigen) deficiency state. Mol Immunol. 2008; 45(9):2660-6. DOI: 10.1016/j.molimm.2007.12.012. View

Kuraya M, Ming Z, Liu X, Matsushita M, Fujita T . Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation. Immunobiology. 2005; 209(9):689-97. DOI: 10.1016/j.imbio.2004.11.001. View

Vander Cruyssen B, Nuytinck L, Boullart L, Elewaut D, Waegeman W, Van Thielen M . Polymorphisms in the ficolin 1 gene (FCN1) are associated with susceptibility to the development of rheumatoid arthritis. Rheumatology (Oxford). 2007; 46(12):1792-5. DOI: 10.1093/rheumatology/kem266. View

Atkinson A, Cedzynski M, Szemraj J, St Swierzko A, Bak-Romaniszyn L, Banasik M . L-ficolin in children with recurrent respiratory infections. Clin Exp Immunol. 2004; 138(3):517-20. PMC: 1809226. DOI: 10.1111/j.1365-2249.2004.02634.x. View

Cedzynski M, Szemraj J, Swierzko A, Bak-Romaniszyn L, Banasik M, Zeman K . Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system. Clin Exp Immunol. 2004; 136(2):304-11. PMC: 1809017. DOI: 10.1111/j.1365-2249.2004.02453.x. View

Munthe-Fog L, Hummelshoj T, Honore C, Madsen H, Permin H, Garred P . Immunodeficiency associated with FCN3 mutation and ficolin-3 deficiency. N Engl J Med. 2009; 360(25):2637-44. DOI: 10.1056/NEJMoa0900381. View

Garcia-Laorden M, Garcia-Saavedra A, Rodriguez de Castro F, Violan J, Rajas O, Blanquer J . Low clinical penetrance of mannose-binding lectin-associated serine protease 2 deficiency. J Allergy Clin Immunol. 2006; 118(6):1383-6. DOI: 10.1016/j.jaci.2006.08.004. View

Fijen C, van den Bogaard R, Schipper M, Mannens M, Schlesinger M, Nordin F . Properdin deficiency: molecular basis and disease association. Mol Immunol. 2000; 36(13-14):863-7. DOI: 10.1016/s0161-5890(99)00107-8. View

Honore C, Rorvig S, Munthe-Fog L, Hummelshoj T, Madsen H, Borregaard N . The innate pattern recognition molecule Ficolin-1 is secreted by monocytes/macrophages and is circulating in human plasma. Mol Immunol. 2008; 45(10):2782-9. DOI: 10.1016/j.molimm.2008.02.005. View

10.

Hummelshoj T, Fog L, Madsen H, Sim R, Garred P . Comparative study of the human ficolins reveals unique features of Ficolin-3 (Hakata antigen). Mol Immunol. 2007; 45(6):1623-32. DOI: 10.1016/j.molimm.2007.10.006. View

11.

Wittenborn T, Thiel S, Jensen L, Nielsen H, Jensenius J . Characteristics and biological variations of M-ficolin, a pattern recognition molecule, in plasma. J Innate Immun. 2010; 2(2):167-80. DOI: 10.1159/000218324. View

12.

Honore C, Rorvig S, Hummelshoj T, Skjoedt M, Borregaard N, Garred P . Tethering of Ficolin-1 to cell surfaces through recognition of sialic acid by the fibrinogen-like domain. J Leukoc Biol. 2010; 88(1):145-58. DOI: 10.1189/jlb.1209802. View

13.

Botto M, Kirschfink M, Macor P, Pickering M, Wurzner R, Tedesco F . Complement in human diseases: Lessons from complement deficiencies. Mol Immunol. 2009; 46(14):2774-83. DOI: 10.1016/j.molimm.2009.04.029. View

14.

Fearon D, Austen K . Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase. J Exp Med. 1975; 142(4):856-63. PMC: 2189935. DOI: 10.1084/jem.142.4.856. View

15.

Messias-Reason I, Kremsner P, Kun J . Functional haplotypes that produce normal ficolin-2 levels protect against clinical leprosy. J Infect Dis. 2009; 199(6):801-4. DOI: 10.1086/597070. View

16.

Munthe-Fog L, Hummelshoj T, Hansen B, Koch C, Madsen H, Skjodt K . The impact of FCN2 polymorphisms and haplotypes on the Ficolin-2 serum levels. Scand J Immunol. 2007; 65(4):383-92. DOI: 10.1111/j.1365-3083.2007.01915.x. View

17.

Kishore U, Reid K . C1q: structure, function, and receptors. Immunopharmacology. 2000; 49(1-2):159-70. DOI: 10.1016/s0162-3109(00)80301-x. View

18.

Spitzer D, Mitchell L, Atkinson J, Hourcade D . Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly. J Immunol. 2007; 179(4):2600-8. DOI: 10.4049/jimmunol.179.4.2600. View

19.

Seelen M, Roos A, Wieslander J, Mollnes T, Sjoholm A, Wurzner R . Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods. 2005; 296(1-2):187-98. DOI: 10.1016/j.jim.2004.11.016. View

20.

Frederiksen P, Thiel S, Larsen C, Jensenius J . M-ficolin, an innate immune defence molecule, binds patterns of acetyl groups and activates complement. Scand J Immunol. 2005; 62(5):462-73. DOI: 10.1111/j.1365-3083.2005.01685.x. View